Literature DB >> 26225612

Venous blood gas analytes during isoflurane anesthesia in black-tailed prairie dogs (Cynomys ludovicianus).

Sara M Gardhouse, David Eshar, Nora Bello, Diane Mason.   

Abstract

OBJECTIVE: To describe changes in venous blood gas analytes during isoflurane anesthesia in black-tailed prairie dogs (Cynomys ludovicianus).
DESIGN: Prospective study. ANIMALS: 16 black-tailed prairie dogs. PROCEDURES: Black-tailed prairie dogs were placed in an anesthesia chamber for induction of general anesthesia, which was maintained with isoflurane in oxygen delivered via mask. Immediately following anesthetic induction, a venous blood sample was obtained from the medial saphenous vein; a second venous blood sample was obtained just prior to anesthetic gas shutoff. An evaluation of venous blood gas analytes was performed on each sample. General linear mixed models with repeated measures were used for data analyses.
RESULTS: Median anesthetic time was 90 minutes (range, 60 to 111 minutes). A significant increase from immediately after induction to completion of anesthesia was observed in Pco2 and mean blood chloride ion, BUN, and creatinine concentrations. A decrease in Po2, mean blood pH, and anion gap was observed from induction of anesthesia to completion. No significant differences during anesthesia were observed in mean base excess or blood bicarbonate, sodium, potassium, calcium, magnesium, blood glucose, lactate, and total CO2 concentrations. No complications occurred during or after anesthesia for any animal. CONCLUSIONS AND CLINICAL RELEVANCE: Examination of prairie dogs often requires general anesthesia, with isoflurane currently the inhalation agent of choice. Results suggested respiratory acidosis and relative azotemia may occur during isoflurane anesthesia of prairie dogs. Given the increased risk associated with anesthesia in small mammals and the propensity for respiratory disease in prairie dogs, insight into physiologic changes associated with isoflurane anesthesia in healthy prairie dogs can aid in perioperative evaluation and anesthetic monitoring in this rodent species.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26225612     DOI: 10.2460/javma.247.4.404

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  6 in total

1.  Comparison of Dexmedetomidine-Ketamine-Midazolam and Isoflurane for Anesthesia of Black-tailed Prairie Dogs (Cynomys ludovicianus).

Authors:  Geoffrey R Browning; David Eshar; Hugues Beaufrere
Journal:  J Am Assoc Lab Anim Sci       Date:  2018-11-05       Impact factor: 1.232

2.  Techniques for Nonterminal Blood Sampling in Black-Tailed Prairie Dogs (Cynomys ludovicianus).

Authors:  Valerie Head; David Eshar; Melissa R Nau
Journal:  J Am Assoc Lab Anim Sci       Date:  2017-03-01       Impact factor: 1.232

3.  Influence of Isoflurane Anesthesia on Plasma Thyroxine Concentrations in Black-tailed Prairie Dogs (Cynomys ludovicianus).

Authors:  David Eshar; Sara M Gardhouse; Hugues Beaufrere
Journal:  J Am Assoc Lab Anim Sci       Date:  2018-04-19       Impact factor: 1.232

4.  Asthma in an Adult Female Vervet Monkey (Chlorocebus sabaeus).

Authors:  Liza S Köster; Bradley Simon; Gilda Rawlins; Amy Beierschmitt
Journal:  Comp Med       Date:  2016-02       Impact factor: 0.982

5.  Pharmacokinetic Profiles of Gabapentin after Oral and Subcutaneous Administration in Black-tailed Prairie Dogs (Cynomys ludovicianus).

Authors:  Patrick O Mills; Cassandra O Tansey; Sarah C Genzer; Matthew R Mauldin; Rex A Howard; Chantal A Kling; Felix R Jackson; Audrey M Matheny; Dawn M Boothe; George W Lathrop; Nathaniel Powell; Nadia Gallardo-Romero
Journal:  J Am Assoc Lab Anim Sci       Date:  2020-03-25       Impact factor: 1.232

6.  Reference Intervals for Plasma Biochemical Variables by Point-of-Care Testing in Captive Black-tailed Prairie Dogs (Cynomys ludovicianus).

Authors:  David Eshar; Sara M Gardhouse; Diana Schwartz; Hugues Beaufrere
Journal:  J Am Assoc Lab Anim Sci       Date:  2018-09-12       Impact factor: 1.232

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.